AU6698900A - Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector - Google Patents

Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector

Info

Publication number
AU6698900A
AU6698900A AU66989/00A AU6698900A AU6698900A AU 6698900 A AU6698900 A AU 6698900A AU 66989/00 A AU66989/00 A AU 66989/00A AU 6698900 A AU6698900 A AU 6698900A AU 6698900 A AU6698900 A AU 6698900A
Authority
AU
Australia
Prior art keywords
virus
mdv
marek
vector
vaccine against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66989/00A
Inventor
Michel Joseph Marie Bublot
Aly Fadly
Eugene Smith
Jill Taylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGRICULTURAL RESEARCH SERVICE
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
AGRICULTURAL RES SERVICE
AGRICULTURAL RESEARCH SERVICE
Merial Select Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AGRICULTURAL RES SERVICE, AGRICULTURAL RESEARCH SERVICE, Merial Select Inc filed Critical AGRICULTURAL RES SERVICE
Publication of AU6698900A publication Critical patent/AU6698900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/11011—Alpharetrovirus, e.g. avian leucosis virus
    • C12N2740/11034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU66989/00A 1999-07-16 2000-07-17 Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector Abandoned AU6698900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14440299P 1999-07-16 1999-07-16
US60144402 1999-07-16
PCT/EP2000/007469 WO2001005988A1 (en) 1999-07-16 2000-07-17 Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector

Publications (1)

Publication Number Publication Date
AU6698900A true AU6698900A (en) 2001-02-05

Family

ID=22508422

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66989/00A Abandoned AU6698900A (en) 1999-07-16 2000-07-17 Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector

Country Status (2)

Country Link
AU (1) AU6698900A (en)
WO (1) WO2001005988A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110408727A (en) * 2019-08-16 2019-11-05 华南农业大学 A kind of CPA primer sets, CPA nucleic acid test strip kit and its application detecting J subgroup avian leucosis virus

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010119112A1 (en) * 2009-04-15 2010-10-21 Ceva Sante Animale Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species
CN101863977B (en) * 2010-05-06 2013-06-19 山东农业大学 J substock lymphoid leuoosis-resistant polyclonal antibody and preparation method thereof
MX344069B (en) 2010-10-18 2016-12-02 Intervet Int Bv Herpesvirus of turkeys vectored vaccine against avian influenza in poultry.
EP2845904A1 (en) * 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
AU2016324316B2 (en) 2015-09-18 2023-02-09 Arch Oncology, Inc. Therapeutic CD47 antibodies
WO2018112051A1 (en) * 2016-12-14 2018-06-21 Merial, Inc. Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
CN106755596A (en) * 2017-02-21 2017-05-31 珠海出入境检验检疫局检验检疫技术中心 K subgroup avian leucosis virus fluorescent quantitation RT PCR detection primers groups and kit
CN108342367B (en) * 2018-02-01 2021-07-20 山东农业大学 Recombinant Marek's virus strain SCA13 strain and application thereof
CN110438261B (en) * 2019-07-29 2022-08-12 华南农业大学 Molecular marker, primer, kit and application for detecting F subgroup avian leukosis virus
CN110981969B (en) * 2019-12-24 2021-12-07 长江大学 ALV-K ELISA kit and detection method thereof
CN112695138A (en) * 2021-01-27 2021-04-23 贵州大学 Triple PCR detection primer for avian leukosis virus A/B/J subgroup and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8821441D0 (en) * 1988-09-13 1988-10-12 Animal Health Inst Viral vectors
ES2070997T3 (en) * 1989-12-04 1995-06-16 Akzo Nobel Nv RECOMBINANT HERPES VIRUSES OF TURKEYS AND LIVING VECTOR VACCINES DERIVED FROM THEM.
FR2728794B1 (en) * 1994-12-30 1997-03-21 Rhone Merieux AVIAN RECOMBINANT VACCINE BASED ON AVIAN HERPES VIRUS, PARTICULARLY AGAINST GUMBORO DISEASE
FR2728795B1 (en) * 1994-12-30 1997-03-21 Rhone Merieux AVIAN RECOMBINANT LIVING VACCINE USING AVIAN HERPES VIRUS AS A VECTOR
US6146641A (en) * 1998-07-21 2000-11-14 The United States Of America As Represented By The Secretary Of Agriculture Avian leukosis virus subgroup J envelope gene product for diagnosis and immunogenic composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110408727A (en) * 2019-08-16 2019-11-05 华南农业大学 A kind of CPA primer sets, CPA nucleic acid test strip kit and its application detecting J subgroup avian leucosis virus

Also Published As

Publication number Publication date
WO2001005988A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
AU6217798A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
PT1403375E (en) Recombinant live vaccine, using avian herpes virus as vector
AU3448797A (en) Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
ZA9711247B (en) Recombinant live avian vaccine using as vector the avian infectious laryngotracheitis virus
AU6698900A (en) Live recombinant vaccine against avian leukosis virus using a marek's disease virus (mdv) virus as vector
DE60040727D1 (en) HUMAN PAPILLOMA VIRUS VACCINE FORMULATIONS
GB2337755B (en) Virus vaccine
AU4869299A (en) Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
EP0728842A3 (en) Live recombinant avian vaccine based on an avianherpes virus, against Gumboro disease
AU8143791A (en) Recombinant marek's disease virus
AU3910097A (en) Live recombinant vaccine comprising inefficiently or non-replicating vir us
UA84667C2 (en) Vaccine directed against infection induced by herpes virus of marek's disease
EP0486106A3 (en) Marek's disease virus vaccine
AU2292600A (en) Varicella-zoster virus vaccines
EP1064947A4 (en) In ovo vaccination of 1 type marek's disease virus
ZA955761B (en) Marek's disease virus vaccine
AU5118199A (en) Avian leukosis virus subgroup j envelope gene product for diagnosis and vaccine
AU5098700A (en) Dna vaccine for protecting an avian against infectious bursal disease virus
AU5240896A (en) Marek's disease vaccine
AU4606000A (en) Vaccine for newcastle disease virus
AU2000252449A1 (en) Recombinant vaccines against infectious bursal disease virus
HUP0200560A2 (en) Bhv-1 gene-deleted virus vaccine
AU1674200A (en) Dna vaccine against infectious bursal disease virus
FR2767335B1 (en) RECOMBINANT CELO AVIAN ADENOVIRUS AS A VACCINE VECTOR
AU4957800A (en) Vaccine against isa virus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase